Atom Therapeutics Co., Ltd

This study is testing whether an experimental drug called ABP-671 can help protect kidney function in people who have both chronic kidney disease and high uric acid levels. About 75 participants will receive either the drug or a placebo for 28 weeks while researchers measure chan…

This study is testing whether an experimental drug called ABP-745 can reduce the amount of plaque buildup in the arteries of people with heart disease. Researchers will compare ABP-745 against a placebo in 200 participants over 52 weeks to see if it safely shrinks plaque. The goa…

This early-stage study aims to understand how a new gout drug, ABP-671, interacts with the standard medication allopurinol when taken together. It will involve about 20 adults with gout who are already taking stable allopurinol therapy. The main goal is to measure drug levels in …